Fig. 6

FOXD1 promotes OSCC progression in vivo. A Xenograft tumors of negative control (NC) and FOXD1 groups. B Tumor volume NC of and FOXD1 groups. C Tumor weight of NC and FOXD1 groups. D Representative IHC images of FOXD1, SNAI2, E‐cadherin, and CD44 in NC and FOXD1 groups in xenograft tumors. E Relative IHC score of FOXD1. F Relative IHC score of SNAI2. G Relative IHC score of N‐cadherin. H Relative IHC score of CD44. I Schematic diagram of the roles of FOXD1 in OSCC